MIRA Pharmaceuticals Inc. (MIRA)

1.07

0.17 (19.26%)

At close: Apr 16, 2025, 3:09 PM

MIRA Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-7.85M	-11.98K	-7.06M	-2.18M	-203.98
Depreciation & Amortization	n/a	732.29K	n/a	n/a	n/a
Stock-Based Compensation	1.92M	2.55M	1.3M	n/a	n/a
Other Working Capital	174.6K	390.38K	146.58K	776.01K	n/a
Other Non-Cash Items	n/a	-9.31M	10.25K	24.37K	n/a
Deferred Income Tax	n/a	401.39K	n/a	n/a	n/a
Change in Working Capital	371.25K	849.93	146.58K	776.01K	n/a
Operating Cash Flow	-5.56M	-5.63M	-5.6M	-1.38M	-203.98
Capital Expenditures	n/a	-1	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	-160K	203.06K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	182.42K	8.78K	402.19K	-520.85K	213.36
Financial Cash Flow	3.79M	8.78K	3.15M	4.18M	213.36
Net Cash Flow	-1.77M	4.25K	-2.46M	2.81M	3.13K
Free Cash Flow	-5.56M	-4.53K	-5.6M	-1.38M	-203.98